Editor-in-Chief Message

July 30, 2026

Dermatitis Impact Factor

Every year, late in the month of June, Clarivate analytics provides the editorial office of Dermatitis with critical information related to our Journal Impact Factor and journal ranking among dermatology journals. The Journal Impact Factor represents the number of citations (the "numerator" of this critical fraction) that occurred during the calendar year 2025 and reported in 2026 for "citable articles" (substantive, peer- reviewed studies and review articles, the denominator of this critical fraction) that were published during the preceding two-year period (calendar years 2023 and 2024). Articles that are not counted in the denominator of our Journal Impact Factor include Editorials, Letters to the Editor, Pearls & Zebras, and Meeting Abstracts. However, citations of these latter categories of publications can be counted in the "numerator" of the calculation of the Journal Impact Factor and thus count in a positive way for augmenting the Journal Impact Factor.

Our Journal Impact Factor for 2026 was 3.4, which is virtually identical to the prior year’s Journal Impact factor of 3.5. This result was obtained by the number of citations in the calendar year 2025 which was 510, with the total number of citable articles at 150 (510/250 = 3.4, the latest Journal Impact Factor). Journal Impact Factors can be labile, but ours has been stable over the last 2 cycles. The editorial office has a listing of journal articles that are highly cited, and conversely, those articles that have not been cited during the 2023- and 2024- time frame. Our five-year Journal Impact factor is 3.7.

The ranking of Dermatology journals based on impact factor is also provided. With our Journal Impact Factor of 3.4, Dermatitis was ranked 25th among 99 Dermatology Journals.

The editorial office of Dermatitis is aware of the decline in our Journal Impact Factor and associated ranking among Dermatology Journals. The reasons for the decline in our Journal Impact Factor are multi-factorial and have been discussed at our Editorial Advisory Board Meetings and at the business meeting of the American Contact Dermatitis Society. Measures to enhance our Journal Impact Factor and scientific ranking among Dermatology journals are being implemented, but take time to "move the needle" in a positive direction.

· · · · · · · · · · · · • ♦ • · · · · · · · · · · · ·

Second Call for submissions: Dermatitis Logo

Dermatitis is calling for submissions for creating a unique Logo for our journal, which is different and distinct from the American Contact Dermatitis Society Logo. The editorial board can potentially enlist the services of a professional design team, but we determined that it is preferable that a logo design be created by a member of the ACDS, who understands its mission and that of the journal.

Our goal is to develop a "Brand Image" for Dermatitis to be used on the journal cover, website and Scholar One submission platform, social media, and journal communications. We look forward to seeing your submissions!

Here are our guidelines for creating a Dermatitis Logo:

  1. The logo can be hand drawn or a software program can be utilized.
  2. Generative AI is permitted to create a logo.
  3. The Logo can be Black & White or Color.
  4. The final logo will be used on the static cover of Dermatitis in 2027.
  5. Submission deadline September 1, 2026.
  6. The Editorial office, along with the new section editor for journal artwork, Dr. Ponciano Cruz, will select the top candidates.
  7. The ACDS membership will vote to select the final Logo for the journal.
  8. Submit candidate images to the Editorial Office of Dermatitis (ju.dermatitis@outlook.com). The submissions can be in the form of a JPEG, PICT or PDF format.
  9. Contact the journal if there are questions about this initiative.

· · · · · · · · · · · · • ♦ • · · · · · · · · · · · ·

Second Call for Submissions: Chronic Hand Eczema (Hand Dermatitis)

Submit your study, review, case report, letter, Pearls & Zebras, Images related to Chronic Hand Eczema by Jan 1, 2027

Coordinating Editor: Anthony Gaspari, MD

The editor of Dermatitis is excited to bring to its readership a state-of-the art comprehensive collection of reviews, studies, letters and Pearls and Zebras on Chronic Hand Eczema and its mechanisms. We especially encourage submissions of original studies in this topic although other types of manuscripts will be considered.

Areas of interest include: clinical trials, treatment modalities, epidemiology/population studies, health care disparities, skin of color, allergy/patch testing, basic science studies, and immunobiology as it related to chronic hand eczema. Case series or case reports will also be considered.

For further questions, please contact the Editor at: aagaspari@gmail.com, Professor, Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College of Thomas Jefferson University.
 

Submitted by:
Anthony Gaspari, MD
Dermatitis Editor-in-Chief

Share